Document Detail

Treatment of macroprolactinomas with the long-acting and repeatable form of bromocriptine: a report on 29 cases.
MedLine Citation:
PMID:  1619019     Owner:  NLM     Status:  MEDLINE    
Twenty-nine patients with macroprolactinomas were treated by monthly intramuscular injections of the long-acting and repeatable form of bromocriptine (Parlodel-LAR) in doses ranging from 50-150 mg. They were divided into two groups: group I consisted of 22 patients who received Parlodel LAR before transsphenoidal adenomectomy; group II was composed of 7 patients with earlier neurosurgery and of 2 patients from group I not cured by transsphenoidal adenomectomy. Duration of therapy varied from 1-12 months, and a total of 104 injections was given. At nadir day, serum PRL levels were situated between less than 1% and 43% of pretreatment values. At day 28 after the first injection, serum PRL levels varied between less than 1% to 139% of initial values. No difference could be detected between the two groups regarding the percent of PRL inhibition. Long-term treatment with Parlodel-LAR resulted in a sustained inhibition of PRL secretion, except for 1 case. Resumption of menstrual cycles occurred in 4 out of 15 women and correction of hypogonadism in 4 out of 14 men. Amelioration of disturbed visual fields was recorded in 3 out of 8 patients. Diminution of the adenoma volume was radiologically documented in 14 out of 22 cases. Only few and mild side effects were recorded. One patient with partial adrenal deficiency suffered from a syncope, but this was prevented by hydrocortisone supplementation during the subsequent Parlodel-LAR administration. In conclusion, Parlodel-LAR proved effective in the treatment of macroprolactinomas, achieving rapid inhibition of PRL secretion, and in some patients amelioration of hypopituitarism, reduction in tumor size, and improvement in visual fields, and caused no serious side effects. It is a valuable preparation to surgery and can also be used in long-term medical therapy.
A Beckers; P Petrossians; R Abs; P Flandroy; T Stadnik; M de Longueville; I Lancranjan; A Stevenaert
Related Documents :
14674719 - The treatment of de novo acromegalic patients with octreotide-lar: efficacy, tolerabili...
24101449 - Influence of ethnicity on the efficacy and utilization of bariatric surgery in the usa.
15260009 - The case of the elusive androgen.
15807869 - Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-t...
10917349 - Microsurgical treatment of symptomatic sacral tarlov cysts.
20453679 - A randomized controlled trial of growth hormone in active pediatric crohn disease.
21309359 - Percutaneous aortic valve implantation.
21109229 - Phototherapeutic keratectomy for the treatment of corneal opacities after epidemic kera...
24909069 - Similarities and differences in the clinical features between cardia varices and esopha...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The Journal of clinical endocrinology and metabolism     Volume:  75     ISSN:  0021-972X     ISO Abbreviation:  J. Clin. Endocrinol. Metab.     Publication Date:  1992 Jul 
Date Detail:
Created Date:  1992-07-31     Completed Date:  1992-07-31     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0375362     Medline TA:  J Clin Endocrinol Metab     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  275-80     Citation Subset:  AIM; IM    
Department of Endocrinology, University of Liège, Belgium.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Bromocriptine / administration & dosage,  adverse effects,  therapeutic use*
Delayed-Action Preparations
Injections, Intramuscular
Middle Aged
Nausea / chemically induced
Pituitary Gland / physiology
Pituitary Neoplasms / drug therapy*
Prolactin / blood,  secretion
Prolactinoma / drug therapy*
Reg. No./Substance:
0/Delayed-Action Preparations; 25614-03-3/Bromocriptine; 9002-62-4/Prolactin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Persistence of impaired insulin secretion in infant rhesus monkeys that had been hyperinsulinemic in...
Next Document:  Growth hormone-releasing hormone-like messenger ribonucleic acid and immunoreactive peptide are pres...